Assessment of erythropoiesis in renal anemia using soluble transferrin receptors

ABSTRACT

To evaluate the clinical usefulness of soluble transferrin receptors [sTFR], 42 patients were enrolled in this study representing four groups. Group I included 10 end stage renal disease [ESRD] patients on HD, EPO and i.v. iron twice-thrice/week [their age ranged from 6 to 12 years with a mean of 7 years]. Group II included 18 ESRD patients on conservative management without regular HD nor erythropoietin, they received maintenance oral iron deficiency anemia with normal kidney functions [their mean age was 6.5 years], they were on iron therapy. Group IV included 13 healthy children with normal Hb level and normal kidney functions [they were age and sex matched as a control group and their mean age was 7 years]. Three parameters for the assessment of erythropoiesis were used in all groups [Hb, sTER and serum ferritin]. Kidney function tests were also determined